Assignee
SPHINGOTEC GMBH
DE·18 granted patents·25 pending applications·17 citations·filing 2005–2023
Top patents by PatentIndex Score
43 records- 0196US11726101B2Adrenomedullin assays and methods for determining mature adrenomedullinSPHINGOTEC GMBH·Filed 2021·Granted Aug 15, 2023·2 cites·18 claims
- 0288US11067586B2Adrenomedullin assays and methods for determining mature adrenomedullinSPHINGOTEC GMBH·Filed 2016·Granted Jul 20, 2021·2 cites·20 claims
- 0388US10114029B2Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunctionSPHINGOTEC GMBH·Filed 2017·Granted Oct 30, 2018·2 cites·50 claims
- 0487US12247988B2Adrenomedullin assays and methods for determining mature andrendomedullinSPHINGOTEC GMBH·Filed 2023·Granted Mar 11, 2025·0 cites·26 claims
- 0587US12228581B2Adrenomedullin assays and methods for determining mature andrendomedullinSPHINGOTEC GMBH·Filed 2023·Granted Feb 18, 2025·0 cites·22 claims
- 0680US9664695B2Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunctionSPHINGOTEC GMBH·Filed 2013·Granted May 30, 2017·2 cites·37 claims
- 0779US7838245B2Use of precursors of tachykinins and/or their fragments in medical diagnosticSPHINGOTEC GMBH·Filed 2005·Granted Nov 23, 2010·5 cites·5 claims
- 0878US9702876B2Method for predicting the risk of getting cancer or diagnosing cancer in a female subjectSPHINGOTEC GMBH·Filed 2013·Granted Jul 11, 2017·2 cites·20 claims
- 0977US12399186B2Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunctionSPHINGOTEC GMBH·Filed 2021·Granted Aug 26, 2025·0 cites·57 claims
- 1077US2023147663A1Method for predicting the risk of getting cancer or diagnosing cancer in a female subjectSPHINGOTEC GMBH·Filed 2022·Application pending·0 cites
- 1174US10900978B2Method for predicting the risk of obesity in a subjectSPHINGOTEC GMBH·Filed 2016·Granted Jan 26, 2021·1 cites·20 claims
- 1274US2023127440A1Method for predicting the risk of incidence of chronic kidney diseaseSPHINGOTEC GMBH·Filed 2022·Application pending·0 cites
- 1373US2023221339A1Adrenomedullin (adm) for diagnosis and/or prediction of dementia and anti-andrenomedullin binder for use in therapy or prevention of dementiaSPHINGOTEC GMBH·Filed 2022·Application pending·0 cites
- 1472US11016107B2Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunctionSPHINGOTEC GMBH·Filed 2018·Granted May 25, 2021·0 cites·11 claims
- 1570US10520512B2Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subjectSPHINGOTEC GMBH·Filed 2013·Granted Dec 31, 2019·1 cites·8 claims
- 1667US2020049721A1Fasting levels of growth hormone as a predictive marker of cardiovascular riskSPHINGOTEC GMBH·Filed 2019·Application pending·0 cites
- 1766US11340240B2Method for predicting the risk of obesity in a subjectSPHINGOTEC GMBH·Filed 2020·Granted May 24, 2022·0 cites·23 claims
- 1866US2021109102A1Method for predicting the risk of getting cancer or diagnosing cancer in a female subjectSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 1966US2020326350A1Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subjectSPHINGOTEC GMBH·Filed 2019·Application pending·0 cites
- 2065US2020249246A1Adrenomedullin to guide therapy of blood pressure declineSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 2164US9535060B2Adrenomedullin assays and methods for determining mature adrenomedullinSPHINGOTEC GMBH·Filed 2012·Granted Jan 3, 2017·0 cites·10 claims
- 2264US2020300868A1Method for predicting the risk of getting a major adverse cardiac eventSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 2362US2017307618A1Method for predicting the risk of getting cancer or diagnosing cancer in a female subjectSPHINGOTEC GMBH·Filed 2017·Application pending·0 cites
- 2462US2020225250A1hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a SubjectSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 2561US2024272178A1A method for predicting sepsis and septic shockSPHINGOTEC GMBH·Filed 2022·Application pending·0 cites
- 2661US2021302440A1Adrenomedullin (adm) for diagnosis and/or prediction of dementia and anti-adrenomedullin binder for use in therapy or prevention of dementiaSPHINGOTEC GMBH·Filed 2019·Application pending·0 cites
- 2759US10598674B2Adrenomedullin to guide therapy of blood pressure declineSPHINGOTEC GMBH·Filed 2014·Granted Mar 24, 2020·0 cites·12 claims
- 2859US2016252526A1A method for predicting the risk of getting a major adverse cardiac eventSPHINGOTEC GMBH·Filed 2014·Application pending·0 cites
- 2959US2015346222A1Fasting levels of growth hormone as a predictive marker of cardiovascular riskSPHINGOTEC GMBH·Filed 2014·Application pending·0 cites
- 3058US11598781B2Method for predicting the risk of incidence of chronic kidney diseaseSPHINGOTEC GMBH·Filed 2016·Granted Mar 7, 2023·0 cites·14 claims
- 3155US10605812B2Method for predicting the risk of getting cancer or diagnosing cancer in a subjectSPHINGOTEC GMBH·Filed 2014·Granted Mar 31, 2020·0 cites·27 claims
- 3255US2021285949A1Pro-adrenomedullin or fragment thereof in patients infected with corona virus and treatments with binder against adrenomedullinSPHINGOTEC GMBH·Filed 2021·Application pending·0 cites
- 3353US2022291234A1A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction in pediatric patientsSPHINGOTEC GMBH·Filed 2020·Application pending·0 cites
- 3452US11844812B2Selenoprotein P for prediction of a first cardiovascular eventSPHINGOTEC GMBH·Filed 2018·Granted Dec 19, 2023·0 cites·10 claims
- 3552US2017234889A1hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a SubjectSPHINGOTEC GMBH·Filed 2015·Application pending·0 cites
- 3652US2023357383A1Anti-ADM-antibodies binding to the free N-terminus for accelerated transition of ADM-Gly to bio-ADM in patients with ADM-Gly/ bio-ADM ratio above a threshold and combination with vitamin CSPHINGOTEC GMBH·Filed 2021·Application pending·0 cites
- 3751US2022043005A1Selenoprotein p in heart failureSPHINGOTEC GMBH·Filed 2019·Application pending·0 cites
- 3847US2020182885A1A method for diagnosing or monitoring kidney function or diagnosing kidney dysfuntionSPHINGOTEC GMBH·Filed 2018·Application pending·0 cites
- 3945US2021223242A1Method for the detection of apolipoprotein e4SPHINGOTEC GMBH·Filed 2017·Application pending·0 cites
- 4045US2024255531A1Mature adrenomedullin for therapy stratification of corticosteroids in critically ill patientsSPHINGOTEC GMBH·Filed 2022·Application pending·0 cites
- 4142US2019376985A1Adrenomedullin for assessing congestion in a subject with acute heart failureSPHINGOTEC GMBH·Filed 2017·Application pending·0 cites
- 4241US2015118236A1Method for Predicting the Risk of Getting a Cardiovascular Event in a Female SubjectSPHINGOTEC GMBH·Filed 2013·Application pending·0 cites
- 4338US2016097781A1Method for stratifying a female subject for hormone replacement therapySPHINGOTEC GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SPHINGOTEC GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →